Biotech Diaries - April 24th, 2024 (feat. Martina Neville, PhD)
Jeff Bissen
10 years in biotech, from bench to business | Driving revenue growth with a background in genome engineering, stem cells, & molecular biology | Follow for life science industry insights ??
Did you miss last week's newsletter? ??
Check out the edition from April 17th if you haven't seen it yet!
Topics included:
?? 10 biotech recruiters I'd personally recommend ??
?? Different types of stem cells, defined by "potency" ??
?? Best cities for biotech/pharma on the West Coast ????
?? Business trip to the Netherlands ????
?? Guest post from Philipp Baaske ??
Here's the link: linkedin.com/pulse/biotech-diaries-april-17th-2024-feat-philipp-baaske-bissen--9sare
Now for this week's newsletter!
New job announcement ??
I officially joined Ncardia as Senior Director of Business Development!
On a mission to perfect the full potential of induced pluripotent stem cells (iPSCs) to transform drug discovery in human healthcare.
A few people correctly guessed my new job in advance because I left hints by posting more about iPSCs, which will continue to be a recurring topic in my content.
Check out the official announcement: linkedin.com/posts/jeffbissen_newjob-ipscs-biotechdiaries-activity-7185636110960631809-vKek
Drug development poll ???
I'm posted a poll, asking my network what part of drug development they focus on.
Drug discovery came in first with pre-clinical research as a close second.
This aligns well with my work with iPSCs, so expect more drug discovery content moving forward.
See the poll results here: linkedin.com/posts/jeffbissen_drugdevelopment-drugdiscovery-biotechdiaries-activity-7185874957527064577-Rwyz
The discovery that transformed biological research ??
In 2007, Shinya Yamanaka and Kazutoshi Takahashi were able to reprogram human somatic cells into pluripotent stem cells by inducing the expression of four embryonic transcription factors.
The resultant cells were called human induced pluripotent stem cells (iPSCs).
领英推荐
iPSCs have unlimited proliferation capacity and can be differentiated into nearly any cell type in the body.
Learn more about iPSCs here: linkedin.com/posts/jeffbissen_drugdiscovery-drugdevelopment-biotechdiaries-activity-7186693811417272320-hkMe
Back home after onboarding in the Netherlands ????
As mentioned above, I recently joined Ncardia, which is headquartered in Leiden (a little southwest of Amsterdam), so I went there for my first week.
The mission: To enable biopharmaceutical companies to accelerate their drug discovery pipelines through the integration of human iPSC technologies.
The vision: Perfecting the full potential of iPSCs to transform drug discovery in human healthcare.
For more about Ncardia's mission and vision, see the link in the comments under this post: linkedin.com/posts/jeffbissen_drugdiscovery-drugdevelopment-biotechdiaries-activity-7187072622436720642-AMv4
Catching up with SRC-Search in Amsterdam ??
SRC-Search was established in 2012 to offer an unrivalled recruitment experience within the diagnostic, life science, analytical, and medical industries.
Clients range from start-ups to small-medium enterprises up to global market-leaders looking to fill positions ranging from entry-level to the board-room.
Their experienced multi-lingual consultants have a deep understanding of biotech and have built an exceptional reputation within it.
Read more about SRC here: linkedin.com/posts/jeffbissen_biotechnology-recruitment-biotechdiaries-activity-7187884826241171456-ZLyQ
This week's guest post: Martina Neville, PhD ??
If you’re wondering whether it’s worth posting on LinkedIn, Martina can attest to the opportunities that can come through this little platform.
She's a PhD scientist, marketing maestro, and podcast host, so she definitely knows what she's talking about when it comes to life science marketing.
Her advice is to accept LinkedIn for what it is and to be your true self.
See her post here: linkedin.com/posts/martina-n_if-youre-wondering-whether-its-worth-posting-activity-7188446641966718979-Q6ap
Subscribe for more life science insights ??
Hi, I'm Jeff Bissen (pronounced BEE-sen), and I have 10 years of biotech experience - first in research and now on the business side of the industry.
Did you enjoy this newsletter?
Click the blue "Subscribe" button below, and share it with your colleagues!
Biotech Diaries is a weekly roundup of my journey as a life science professional, plus guest posts from industry leaders.
As Editor-in-Chief for Podcast Magazine?, I've acquired insider information about what makes podcasts profitable. Now, I use that insight to help professionals ??= Skyrocket their Sales =?? using the Power of Podcasting
7 个月Exciting updates. Looking forward to more insights from your experienced perspective.
I make the invisible visible | Co-Founder & CEO NanoTemper | ?? Biophysical Tools for Biotech ??
7 个月Nice post and insights - thank you dear Jeff!
Strategic Business Development, Customer Success, and Partnerships
7 个月exciting news, looking forward to more updates. ??
Cell & Gene Therapy | Pharmacology | Cardiovascular Disease
7 个月You provided insightful perspectives and a wealth of knowledge on the biotech industry, Jeff! Thank you.
Lab Scientist Turned Science Marketer | Developer of Business | Creator of the Blooming Late Scientists Podcast
7 个月Jeff Bissen ?????? that is really kind of you to feature my post. Thank you!